Model Medicines

0 followers


Model Medicines is transforming drug discovery by leveraging the historical compendium of drug development data and unbiased AI to create Phase II/III ready drug candidates in days rather than decades.

Industries

Employees

11-50

Links

Org chart

Daniel Haders II
Founder & CEO

Daniel Haders II

Collapse
Sean M. Russell
Founder, COO
Joyce Batasin
Scientific Marketing Associate
Bret Awbrey
VP of Finance
Tyler Umansky
Manager, Machine Learning
Mihai Stirbat
Machine Learning Engineer

Board & advisors

Tushar Menon
Scientific Advisor
William Brubaker
Preclinical Development Advisor
Davey Smith
Lead Clinical Advisor
Tim Considine
Corporate Development Advisor
Bill Malloy
Board Observer
Armen Vidian
Board Observer
David Garvey
Preclinical Advisor
Kip Quackenbush
Board Member
Arnab Chatterjee
Preclinical Development Partner & Advisor
Sumit Chanda
Preclinical Development Partner & Advisor
Adolfo Garcia-Sastre
Preclinical Development Partner & Advisor
Kris White
Preclinical Development Partner & Advisor